![Glynn Wilson](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Glynn Wilson
Direktör/Styrelseledamot på
CADRENAL THERAPEUTICS, INC.
Förmögenhet: 571 532 $ per 2026-05-31
Profil
Dr. Glynn Wilson is a Chief Executive Officer & Director at Caring Brands, Inc. and an Independent Director at Cadrenal Therapeutics, Inc. He is on the Board of Directors at Caring Brands, Inc. and Cadrenal Therapeutics, Inc. Dr. Wilson was previously employed as a Chief Scientific Officer by Bonk, Inc., a Chief Scientific Officer by Auriga Laboratories, Inc. /Old/, a Chairman by TapImmune, Inc., a Chairman by Tapimmune, Inc., a President & Chief Executive Officer by PharmaSpec Corp., a Vice President-Research & Development by PlasmaTech Biopharmaceuticals, Inc., a Chief Scientific Officer by Tacora Corp, a Head-Worldwide Drug Delivery by Smithkline Beecham Plc, a Research Head-Cell & Molecular Biology by Ciba-Geigy Pharmaceuticals, and a President & Chief Executive Officer by The GW Group.
He received his doctorate degree from The Rockefeller University.
Kända innehav i offentliga företag
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
5,5 % | 2026-05-04 | 500 000 ( 5,5 % ) | 555 000 $ | 2026-05-31 |
| 2025-07-28 | 3 333 ( 0,12 % ) | 16 532 $ | 2026-05-31 |
Aktiva positioner av Glynn Wilson
| Företag | Position | Start |
|---|---|---|
| CADRENAL THERAPEUTICS, INC. | Direktör/Styrelseledamot | 2023-01-19 |
Tidigare kända positioner av Glynn Wilson
| Företag | Position | Slut |
|---|---|---|
| MARKER THERAPEUTICS, INC. | Verkställande Direktör | 2017-09-25 |
Tapimmune, Inc. | Verkställande Direktör | 2017-09-01 |
Auriga Laboratories, Inc. /Old/
 Auriga Laboratories, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Researches and develops pharmaceutical products | President | 2006-03-13 |
PharmaSpec Corp. | President | 2000-01-01 |
| ABEONA THERAPEUTICS INC. | Teknisk/Vetenskaplig/F&U Direktör | 1998-01-01 |
Glynn Wilsons utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
61
Första gradens relationer
12
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 12 |
|---|---|
Abeona Therapeutics, Inc.
 Abeona Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes cell and gene therapies for life-threatening rare genetic diseases | Health Technology |
Smithkline Beecham Plc
 Smithkline Beecham Plc Pharmaceuticals: OtherHealth Technology Develops and manufactures pharmaceutical products | Health Technology |
Marker Therapeutics, Inc.
 Marker Therapeutics, Inc. BiotechnologyHealth Technology Develops and commercializes cell based immune therapeutics and vaccines for cancer treatment | Health Technology |
Auriga Laboratories, Inc. /Old/
Auriga Laboratories, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Researches and develops pharmaceutical products | Health Technology |
Tacora Corp
 Tacora Corp Miscellaneous Commercial ServicesCommercial Services Develops bioresponsive smart polymers | Commercial Services |
The Rockefeller University
 The Rockefeller University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The GW Group | |
PharmaSpec Corp. | |
Ciba-Geigy Pharmaceuticals | |
Safety Shot, Inc.
 Safety Shot, Inc. Pharmaceuticals: OtherHealth Technology Manufactures photocil dietary supplement products | Health Technology |
Tapimmune, Inc. | |
Cadrenal Therapeutics, Inc.
 Cadrenal Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops novel therapy with orphan drug indication | Health Technology |
